Facebook
X
LinkedIn
ForwardPrecision Medicine in Breast Cancer: Navigating Access, Evidence, and Emerging Therapies in Managed Care
Recorded on Saturday, September 19, 2026 at 1-2pm PT
Pricing: Free for Members and Non-Members
Course Description
Precision medicine is rapidly transforming breast cancer care through advances in genomic profiling, molecular subtyping, targeted therapies, and companion diagnostics. This program will provide an overview of the evolving breast cancer landscape and examine how precision medicine approaches are improving treatment selection, outcomes, and quality of life for patients. Faculty will review emerging therapies and the growing body of real-world evidence that supports managed care decision-making, particularly for novel and accelerated-approval treatments. Through case-based discussions, participants will explore the practical application of precision oncology evidence and strategies for integrating these therapies into managed care practice. The session will also address regional access challenges, reimbursement considerations, and payer approaches to improving equitable access to precision medicine for patients with breast cancer.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
Review the impact of genomic profiling and molecular subtyping in breast cancer classification, treatment selection, and individualized therapeutic approaches to optimize patient outcomes.
Identify regional payer strategies to address gaps and delays in access to precision medicine for breast cancer patients, including policy and benefit design considerations.
Evaluate the role of real-world evidence (RWE) in informing managed care decisions for precision medicine therapies, particularly those granted accelerated approval.
Identify key emerging precision therapies in breast cancer, focusing on enhanced treatment efficacy, minimizing adverse effects, and improving the quality of life for breast cancer patients.
Commercial Support
This activity is supported by an independent medical education grant from AstraZeneca Pharmaceuticals.
Course summary
- 1.00 ACPE
The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Moderator:
Charlie Dragovich
Speakers:
Abby Kim, PharmD, BCOP
Senior Director, Clinical Strategy and Oncology Specialty Solutions
Prime Therapeutics
Farah Raheem, Pharm.D., BCOP
Clinical Pharmacy Specialist, Hematology/Oncology
Mayo Clinic Arizona
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN: 0233-0000-26-044-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.00
Release Date: October 12, 2026 • Expiration Date: December 31, 2027
Activity Fee: Free for Members and Non-members
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
Successful Completion to Obtain Credit:
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at the AMCP California Day of Education. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
Available Credit
- 1.00 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Price
Required Hardware/software
Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online activities.